10-Q Filing

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC CIK: 1730430 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001558370-19-009978`
Period End Date	20190930
Filing Date	20191105
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	knsa-20190930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 54 Income Statement 64 Cash Flow Statement 56 Stockholders Equity 44

Balance Sheet 54 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$71.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$68.81M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$189.94M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$235.33M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$9.60M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.45M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$313.75M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$268.34M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.41M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.36M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.22M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$3.68M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$210.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$210.00K	USD	Point-in-time
Deferred offering costs	`DeferredCosts`	$433.00K	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$1.22M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$4.63M	USD	Point-in-time
Total assets	`Assets`	$321.96M	USD	Point-in-time
Total assets	`Assets`	$281.81M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.92M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.44M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$19.36M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$16.42M	USD	Point-in-time
Accrued milestones	`AccruedMilestoneLiabilitiesCurrent`	$150.00K	USD	Point-in-time
Accrued milestones	`AccruedMilestoneLiabilitiesCurrent`	$15.00M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.61M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$218.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$42.55M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$27.56M	USD	Point-in-time
Noncurrent operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$1.39M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$144.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$943.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$29.89M	USD	Point-in-time
Total liabilities	`Liabilities`	$42.70M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$576.13M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$473.48M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$62.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-4.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-324.30M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-194.22M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$306.52M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$318.91M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$279.27M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$275.20M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$251.91M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$341.80M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$-105.11M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$321.96M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$281.81M	USD	Point-in-time

Income Statement 64 line items

Line Item	Tag	Value	Unit	Period
Research and development expense	`ResearchAndDevelopmentExpense`	$20.64M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$22.01M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$112.11M	USD	3 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$50.48M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$13.55M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.51M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$8.43M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$25.27M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$26.16M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$137.38M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$64.03M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$30.45M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-30.45M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-26.16M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-137.38M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-64.03M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.39M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.62M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.99M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$4.92M	USD	3 Qtrs
Loss before benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-24.54M	USD	1 Quarter
Loss before benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-29.06M	USD	1 Quarter
Loss before benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-132.46M	USD	3 Qtrs
Loss before benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-61.03M	USD	3 Qtrs
Benefit for income taxes	`IncomeTaxExpenseBenefit`	$-2.39M	USD	3 Qtrs
Benefit for income taxes	`IncomeTaxExpenseBenefit`	$-386.00K	USD	3 Qtrs
Benefit for income taxes	`IncomeTaxExpenseBenefit`	$-2.00M	USD	1 Quarter
Benefit for income taxes	`IncomeTaxExpenseBenefit`	$-131.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.98M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-60.65M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-20.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-27.06M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-24.41M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-130.07M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-65.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.19M	USD	1 Quarter
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.62	USD	3 Qtrs
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.51	USD	1 Quarter
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.42	USD	3 Qtrs
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.49	USD	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	54.83M	shares	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	48.18M	shares	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	53.77M	shares	3 Qtrs
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	23.17M	shares	3 Qtrs
Net loss	`NetIncomeLoss`	$-60.65M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-20.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.98M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-27.06M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-130.07M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-65.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-24.41M	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-62.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$66.00K	USD	3 Qtrs
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$7.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$12.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-39.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$93.00K	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-39.00K	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$66.00K	USD	3 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-24.41M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-60.65M	USD	3 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-27.10M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-130.00M	USD	3 Qtrs

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-130.07M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-60.65M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$32.00K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$1.50M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$12.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$523.00K	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$3.12M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$10.12M	USD	3 Qtrs
Class A common shares issued or to be issued as consideration for Primatope, including milestone payments	`IssuanceOfStockForAcquisition`	$8.80M	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-23.00K	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-66.00K	USD	3 Qtrs
Non-cash rent expense	`NonCashRentExpense`	$258.00K	USD	3 Qtrs
Accretion of discounts on short-term investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$3.04M	USD	3 Qtrs
Accretion of discounts on short-term investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$670.00K	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-3.41M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-935.00K	USD	3 Qtrs
Prepaid expenses, right-of-use assets and other assets	`IncreaseDecreaseInPrepaidExpenseRightOfUseAssetsAndOtherAssets`	$4.03M	USD	3 Qtrs
Prepaid expenses, right-of-use assets and other assets	`IncreaseDecreaseInPrepaidExpenseRightOfUseAssetsAndOtherAssets`	$1.47M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.98M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-4.50M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$6.45M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$2.69M	USD	3 Qtrs
Accrued milestones	`IncreaseDecreaseInAccruedMilestone`	$-14.85M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-916.00K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$943.00K	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-53.37M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-134.20M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.21M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.27M	USD	3 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$406.13M	USD	3 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$292.58M	USD	3 Qtrs
Proceeds from the maturities of short-term investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments`	$25.00M	USD	3 Qtrs
Proceeds from the maturities of short-term investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments`	$454.64M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-268.86M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$47.30M	USD	3 Qtrs
Payments of offering costs	`PaymentsOfStockIssuanceCosts`	$118.00K	USD	3 Qtrs
Payments of offering costs	`PaymentsOfStockIssuanceCosts`	$3.65M	USD	3 Qtrs
Proceeds from exercise of options and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$746.00K	USD	3 Qtrs
Proceeds from exercise of options and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$76.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$83.73M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$346.44M	USD	3 Qtrs
Net increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-3.17M	USD	3 Qtrs
Net increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$24.21M	USD	3 Qtrs
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.66M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.87M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.19M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.02M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.66M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.87M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.19M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.02M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$345.00K	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$1.73M	USD	3 Qtrs
Deferred offering costs included in accrued expenses and accounts payable	`DeferredOfferingCostsIncludedInAccruedExpensesAndAccountsPayable`	$11.00K	USD	3 Qtrs
Property and equipment included in accrued expenses and accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$1.06M	USD	3 Qtrs
Property and equipment included in accrued expenses and accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$371.00K	USD	3 Qtrs

Stockholders Equity 44 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of the period	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$306.52M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$318.91M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$279.27M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$275.20M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$251.91M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$341.80M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$-105.11M	USD	Point-in-time
Conversion of convertible preferred shares into common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$310.59M	USD	1 Quarter
Common shares issued or to be issued in connection with the acquisition of all issued and outstanding equity securities of Primatope Therapeutics, Inc.	`StockIssuedDuringPeriodValueAcquisitions`	$7.00M	USD	1 Quarter
Common shares issued or to be issued in connection with a milestone payment due to Primatope Therapeutics, Inc.	`StockIssuedDuringPeriodValueMilestonePayments`	$1.80M	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$59.00K	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$17.00K	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$53.00K	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$181.00K	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$512.00K	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.50M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.46M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.06M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$558.00K	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.89M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.76M	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-62.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$66.00K	USD	3 Qtrs
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$7.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$12.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-39.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$93.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-60.65M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-20.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.98M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-27.06M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-24.41M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-65.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-130.07M	USD	3 Qtrs
Balance at the end of the period	`StockholdersEquity`	$341.80M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$306.52M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$318.91M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$279.27M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$275.20M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$251.91M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$-105.11M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.